# EDIT (Editas Medicine, Inc.) - SEC EDGAR Financial Statements

> Editas Medicine, Inc. reported $49.83M in revenue and a net loss of $72.22M for the trailing twelve months ended September 30, 2026 (up 37.4% year over year), with a -151.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/EDIT
- Markdown: https://convexityos.com/fundamentals/EDIT.md
- SEC CIK: 0001650664
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:38 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001650664&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $49.83M | +37.4% YoY |
| Operating Income | TTM | -$75.59M | -151.7% margin |
| Net Income | TTM | -$72.22M | -145.0% net margin |
| Diluted EPS | TTM | -$0.47 | Split-adjusted |
| Free Cash Flow | TTM | -$110.5M | -221.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $190.2M | Total debt: $70.76M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $40.52M | $32.31M | $78.12M | $19.71M | $25.54M | $90.73M | $20.53M | $31.94M | $13.73M | $6.05M |
| Research & Development | $89.95M | $199.2M | $177.7M | $175.0M | $142.5M | $158.0M | $96.90M | $90.65M | $83.16M | $56.98M |
| Total Operating Expenses | $200.5M | $283.5M | $247.3M | $245.7M | $218.7M | $225.6M | $161.5M | $145.7M | $133.7M | $103.2M |
| **Operating Income** | -$160.0M | -$251.2M | -$169.2M | -$225.9M | -$193.1M | -$134.8M | -$140.9M | -$113.7M | -$119.9M | -$97.19M |
| **EBITDA** | -$154.7M | -$245.3M | -$163.1M | -$219.6M | -$188.1M | -$130.9M | -$138.1M | -$110.5M | -$117.2M | -$95.99M |
| Interest Expense | $2.13M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| **Net Income** | -$160.1M | -$237.1M | -$153.2M | -$220.4M | -$192.5M | -$116.0M | -$133.7M | -$110.0M | -$120.3M | -$97.18M |
| Basic EPS | -$1.80 | -$2.88 | -$2.02 | -$3.21 | -$2.85 | -$1.98 | -$2.68 | -$2.33 | -$2.98 | -$3.02 |
| **Diluted EPS** | -$1.80 | -$2.88 | -$2.02 | -$3.21 | -$2.85 | -$1.98 | -$2.68 | -$2.33 | -$2.98 | -$3.02 |
| Basic Shares Outstanding | 88.7M | 82.3M | 76.0M | 68.7M | 67.6M | 58.6M | 50.0M | 47.1M | 40.3M | 32.2M |
| Diluted Shares Outstanding | 88.7M | 82.3M | 76.0M | 68.7M | 67.6M | 58.6M | 50.0M | 47.1M | 40.3M | 32.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $10.37M | $11.89M | $2.83M | $24.74M | $7.54M | $3.58M | $4.66M | $30.60M |
| Research & Development | $21.17M | $20.18M | $17.60M | $27.40M | $19.77M | $16.18M | $26.59M | $48.61M |
| Total Operating Expenses | $34.65M | $30.44M | $27.83M | $32.50M | $32.09M | $55.12M | $80.82M | $77.20M |
| **Operating Income** | -$24.28M | -$18.55M | -$25.00M | -$7.75M | -$24.55M | -$51.54M | -$76.16M | -$46.59M |
| **EBITDA** | -$23.90M | -$18.14M | -$24.52M | -$6.95M | -$23.83M | -$49.71M | -$74.25M | -$45.21M |
| Interest Expense | $0 | $0 | $5.00M | $0 | $0 | $0 | $2.13M | $2.19M |
| **Net Income** | -$23.39M | -$18.23M | -$24.98M | -$5.62M | -$25.12M | -$53.23M | -$76.09M | -$45.40M |
| Basic EPS | -$0.15 | -$0.15 | -$0.26 | -- | -$0.28 | -$0.63 | -$0.92 | -- |
| **Diluted EPS** | -$0.15 | -$0.15 | -$0.26 | -- | -$0.28 | -$0.63 | -$0.92 | -- |
| Basic Shares Outstanding | 153.6M | 119.3M | 97.9M | -- | 90.1M | 84.4M | 83.1M | -- |
| Diluted Shares Outstanding | 153.6M | 119.3M | 97.9M | -- | 90.1M | 84.4M | 83.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $146.6M | $131.5M | $123.7M | $141.5M | $203.5M | $139.7M | $238.2M | $134.8M | $146.6M | $185.3M |
| Short-Term Investments | $0 | $138.4M | $199.5M | $202.8M | $296.3M | $262.4M | $219.0M | $234.2M | $182.5M | -- |
| **Cash & Short-Term Investments** | $146.6M | $269.9M | $323.1M | $344.3M | $499.8M | $402.1M | $457.1M | $369.0M | $329.1M | $185.3M |
| Accounts Receivable, Net | $15.18M | $16.27M | $10.19M | $5.14M | $267K | $6.05M | $418K | $30K | $679K | $88K |
| **Total Current Assets** | $163.9M | $289.3M | $340.8M | $356.8M | $507.3M | $419.1M | $463.8M | $374.8M | $332.2M | $187.2M |
| Property, Plant & Equipment, Net | $3.54M | $14.50M | $12.03M | $15.57M | $17.12M | $14.02M | $10.89M | $40.23M | $39.44M | $40.38M |
| Long-Term Investments | -- | $0 | $104.0M | $93.10M | $120.1M | $109.7M | -- | -- | -- | -- |
| Other Non-Current Assets | $2.98M | $5.22M | $8.59M | $5.25M | $6.81M | $4.70M | $5.39M | $5.38M | $1.62M | $1.62M |
| **Total Non-Current Assets** | $22.64M | $52.27M | $158.3M | $157.6M | $170.2M | $153.5M | $45.04M | $45.61M | $41.06M | $42.00M |
| **Total Assets** | $186.5M | $341.6M | $499.2M | $514.3M | $677.5M | $572.6M | $508.9M | $420.4M | $373.3M | $229.2M |
| Accounts Payable | $2.60M | $5.49M | $8.27M | $9.51M | $5.05M | $6.41M | $5.84M | $5.33M | $4.02M | $4.64M |
| Short-Term Debt | $5.00M | $5.00M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | $0 | $6.22M | $8.22M | $8.22M | $11.33M | $20.94M | $23.51M | $15.71M | $13.24M | $256K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | $2.68M | $2.05M | $900K | $748K |
| **Total Current Liabilities** | $46.25M | $77.22M | $63.22M | $60.11M | $46.88M | $58.21M | $59.96M | $35.90M | $36.71M | $33.08M |
| Long-Term Debt | $53.60M | $52.43M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $44.51M | $54.20M | $60.67M | $60.67M | $60.89M | $73.98M | $163.2M | $115.6M | $94.72M | $26.00M |
| Other Non-Current Liabilities | $2.81M | $3.07M | $1.80M | $0 | -- | $27.50M | $1.0K | $293K | $317K | $396K |
| **Total Non-Current Liabilities** | $113.0M | $130.1M | $86.84M | $93.53M | $76.96M | $120.8M | $186.5M | $148.3M | $128.5M | $61.49M |
| **Total Liabilities** | $159.2M | $207.3M | $150.1M | $153.6M | $123.8M | $179.0M | $246.4M | $184.2M | $165.2M | $94.58M |
| **Total Debt (incl. Leases)** | $76.71M | $92.47M | $36.54M | $43.95M | $26.33M | $26.14M | $29.08M | $32.42M | -- | -- |
| Common Stock | $10K | $8.0K | $8.0K | $7.0K | $7.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K |
| Retained Earnings | -$1.63B | -$1.47B | -$1.23B | -$1.08B | -$857.7M | -$665.2M | -$549.2M | -$416.3M | -$305.9M | -$185.5M |
| Accumulated Other Comp. Income | $0 | $268K | $198K | -$3.60M | -$493K | -$46K | $107K | -$29K | -$76K | -- |
| **Total Stockholders' Equity** | $27.29M | $134.3M | $349.1M | $360.7M | $553.6M | $393.6M | $262.4M | $236.2M | $208.1M | $134.6M |
| Total Equity | $27.29M | $134.3M | $349.1M | $360.7M | $553.6M | $393.6M | $262.4M | $236.2M | $208.1M | $134.6M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $93.17M | $181.8M | $123.6M | $146.6M | $165.6M | $138.5M | $138.7M | $131.5M |
| Short-Term Investments | $97.03M | $29.83M | -- | $0 | $0 | $39.96M | $82.27M | $138.4M |
| **Cash & Short-Term Investments** | $190.2M | $211.6M | $123.6M | $146.6M | $165.6M | $178.5M | $221.0M | $269.9M |
| Accounts Receivable, Net | $7.73M | $2.73M | $2.59M | $15.18M | $8.13M | $588K | $510K | $16.27M |
| **Total Current Assets** | $202.0M | $218.1M | $128.1M | $163.9M | $176.9M | $182.8M | $224.8M | $289.3M |
| Property, Plant & Equipment, Net | $2.19M | $2.57M | $2.88M | $3.54M | $4.29M | $4.58M | $8.18M | $14.50M |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| Other Non-Current Assets | $2.98M | $2.98M | $2.98M | $2.98M | $2.99M | $4.20M | $4.20M | $5.22M |
| **Total Non-Current Assets** | $17.44M | $19.30M | $21.27M | $22.64M | $24.86M | $27.79M | $38.81M | $52.27M |
| **Total Assets** | $219.4M | $237.4M | $149.3M | $186.5M | $201.8M | $210.6M | $263.7M | $341.6M |
| Accounts Payable | $6.82M | $4.74M | $4.33M | $2.60M | $3.16M | $6.72M | $5.46M | $5.49M |
| Short-Term Debt | $7.50M | $7.50M | $7.50M | $5.00M | $5.00M | $5.00M | $5.00M | $5.00M |
| Deferred Revenue (Current) | $32.31M | $32.31M | -- | $0 | $0 | $0 | $2.00M | $6.22M |
| **Total Current Liabilities** | $71.58M | $68.43M | $39.78M | $46.25M | $61.77M | $65.94M | $73.11M | $77.22M |
| Long-Term Debt | $49.32M | $48.24M | $47.18M | $53.60M | $54.07M | $51.67M | $49.58M | $52.43M |
| Deferred Revenue (Non-Current) | $4.00M | $4.00M | $44.51M | $44.51M | $54.20M | $54.20M | $54.20M | $54.20M |
| Other Non-Current Liabilities | $2.56M | $2.41M | $2.87M | $2.81M | $4.69M | $4.59M | $6.36M | $3.07M |
| **Total Non-Current Liabilities** | $63.31M | $63.65M | $105.2M | $113.0M | $126.5M | $125.5M | $128.1M | $130.1M |
| **Total Liabilities** | $134.9M | $132.1M | $144.9M | $159.2M | $188.3M | $191.4M | $201.2M | $207.3M |
| **Total Debt (incl. Leases)** | $70.76M | $71.25M | $71.97M | $76.71M | $78.72M | $77.81M | $85.71M | $92.47M |
| Common Stock | $15K | $15K | $10K | $10K | $9.0K | $9.0K | $8.0K | $8.0K |
| Retained Earnings | -$1.70B | -$1.67B | -$1.65B | -$1.63B | -$1.62B | -$1.60B | -$1.54B | -$1.47B |
| Accumulated Other Comp. Income | -$96K | -$6.0K | $0 | $0 | $0 | $15K | $88K | $268K |
| **Total Stockholders' Equity** | $84.52M | $105.3M | $4.41M | $27.29M | $13.45M | $19.19M | $62.42M | $134.3M |
| Total Equity | $84.52M | $105.3M | $4.41M | $27.29M | $13.45M | $19.19M | $62.42M | $134.3M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$160.1M | -$237.1M | -$153.2M | -$220.4M | -$192.5M | -$116.0M | -$133.7M | -$110.0M | -$120.3M | -$97.18M |
| Depreciation & Amortization | $5.28M | $5.81M | $6.06M | $6.34M | $5.05M | $3.96M | $2.83M | $3.25M | $2.68M | $1.20M |
| Stock-Based Compensation | $10.00M | $21.42M | $19.80M | $29.29M | $43.40M | $23.16M | $27.24M | $26.60M | $23.36M | $16.88M |
| Change in Receivables | $1.09M | -$6.08M | -$5.04M | -$4.88M | $5.78M | -$5.63M | -$388K | $649K | -$591K | $931K |
| Change in Payables | -$2.89M | -$2.29M | -$1.49M | $4.37M | -$1.14M | $855K | $274K | $1.78M | -$1.51M | $3.25M |
| **Operating Cash Flow** | -$165.2M | -$210.3M | -$132.2M | -$177.3M | -$163.8M | -$179.8M | -$40.67M | -$45.71M | -$9.42M | -$50.25M |
| Capital Expenditure | -$607K | -$8.83M | -$4.72M | -$4.12M | -$7.98M | -$7.16M | -$6.17M | -$4.75M | -$2.06M | -$3.49M |
| **Free Cash Flow** | -$165.8M | -$219.1M | -$136.9M | -$181.5M | -$171.8M | -$187.0M | -$46.84M | -$50.46M | -$11.48M | -$53.74M |
| Purchases of Investments | $0 | -$86.22M | -$258.5M | -$315.2M | -$408.9M | -$458.4M | -$342.2M | -$459.4M | -$375.3M | -- |
| **Investing Cash Flow** | $138.7M | $162.1M | -$3.73M | $114.1M | -$54.47M | -$140.5M | $12.25M | -$53.09M | -$183.8M | -$3.47M |
| Common Stock Issued | $42.85M | $0 | $117.1M | $0 | $249.5M | $203.7M | $116.3M | $76.79M | $154.1M | $97.49M |
| **Financing Cash Flow** | $40.47M | $56.03M | $118.0M | $1.28M | $282.1M | $224.1M | $131.8M | $86.94M | $154.5M | $97.16M |
| **Net Change in Cash** | $13.90M | $7.89M | -$17.87M | -$62.00M | $63.84M | -$96.24M | $103.4M | -$11.85M | -$38.69M | $43.44M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$23.39M | -$18.23M | -$24.98M | -$5.62M | -$25.12M | -$53.23M | -$76.09M | -$45.40M |
| Depreciation & Amortization | $385K | $416K | $483K | $805K | $721K | $1.83M | $1.92M | $1.38M |
| Stock-Based Compensation | $2.57M | $2.19M | $2.10M | $2.13M | $2.23M | $2.66M | $2.98M | $4.02M |
| Change in Receivables | -$5.00M | -$133K | $12.58M | -$7.05M | -$7.54M | -$78K | $15.76M | -$16.14M |
| Change in Payables | $2.54M | -$58K | $1.73M | -$558K | -$3.56M | $1.26M | -$27K | -$7.00M |
| **Operating Cash Flow** | -$21.19M | -$29.57M | -$23.06M | -$36.39M | -$30.84M | -$50.21M | -$47.80M | -$50.76M |
| Capital Expenditure | $0 | -$106K | -$92K | -$60K | -$433K | $0 | -$114K | -$540K |
| **Free Cash Flow** | -$21.19M | -$29.67M | -$23.15M | -$36.45M | -$31.28M | -$50.21M | -$47.91M | -$51.30M |
| Purchases of Investments | -- | -- | -- | $0 | $0 | $0 | $0 | $4.0K |
| **Investing Cash Flow** | -$66.99M | -$29.80M | $64K | $58K | $39.57M | $42.65M | $56.39M | $30.96M |
| Common Stock Issued | -$619K | $117.5M | $0 | $17.08M | $17.15M | $7.18M | $1.44M | $0 |
| **Financing Cash Flow** | -$468K | $117.5M | $0 | $17.33M | $17.17M | $7.41M | -$1.44M | $55.51M |
| **Net Change in Cash** | -$88.65M | $58.17M | -$23.00M | -$19.00M | $25.90M | -$150K | $7.15M | $35.71M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% | -148.6% | -686.4% | -356.1% | -873.6% | -1605.6% |
| **Net Profit Margin** | -395.0% | -733.7% | -196.1% | -1118.3% | -753.6% | -127.8% | -651.4% | -344.3% | -876.5% | -1605.5% |
| Return on Equity (ROE) | -586.6% | -176.6% | -43.9% | -61.1% | -34.8% | -29.5% | -51.0% | -46.6% | -57.8% | -72.2% |
| Return on Assets (ROA) | -85.8% | -69.4% | -30.7% | -42.9% | -28.4% | -20.3% | -26.3% | -26.2% | -32.2% | -42.4% |
| Current Ratio | 3.54x | 3.75x | 5.39x | 5.94x | 10.82x | 7.20x | 7.74x | 10.44x | 9.05x | 5.66x |
| Quick Ratio | 3.50x | 3.71x | 5.27x | 5.81x | 10.67x | 7.01x | 7.63x | 10.28x | 8.99x | 5.60x |
| Debt to Equity | 2.81x | 0.69x | 0.10x | 0.12x | 0.05x | 0.07x | 0.11x | 0.14x | -- | -- |
| **Revenue Growth (YoY)** | +25.4% | -58.6% | +296.3% | -22.8% | -71.8% | +341.9% | -35.7% | +132.6% | +126.8% | -- |
| 5Y Revenue / Share Growth | -70.5% | -4.5% | +51.7% | -15.7% | +101.1% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -151.7% | -161.4% | -281.3% | -394.9% | -428.7% | -616.9% | -726.4% | -777.3% |
| **Net Profit Margin** | -145.0% | -157.3% | -281.6% | -395.0% | -430.8% | -608.9% | -701.1% | -733.7% |
| Return on Equity (ROE) | -85.5% | -70.2% | -2471.7% | -586.6% | -1485.4% | -1234.3% | -402.5% | -176.6% |
| Return on Assets (ROA) | -32.9% | -31.2% | -73.0% | -85.8% | -99.1% | -112.5% | -95.3% | -69.4% |
| Current Ratio | 2.82x | 3.19x | 3.22x | 3.54x | 2.86x | 2.77x | 3.08x | 3.75x |
| Quick Ratio | 2.77x | 3.13x | 3.17x | 3.50x | 2.81x | 2.72x | 3.03x | 3.71x |
| Debt to Equity | 0.84x | 0.68x | 16.33x | 2.81x | 5.85x | 4.05x | 1.37x | 0.69x |
| **Revenue Growth (YoY)** | +37.4% | +232.3% | -39.2% | -19.2% | +12265.6% | +597.5% | +310.4% | -49.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
